EMBO/EMBL Symposium: Mechanisms of Neurodegeneration 2015

  • Conference Call
  • The European Molecular Biology Laboratory (EMBL) is kindly inviting you to participate in the 2015 EMBO | EMBL Symposium on Mechanism of Neurodegeneration, held June 14 – 17, 2015 in Heidelberg, Germany.


    Neurodegenerative diseases represent a major challenge for today’s society in terms of the large and rapidly increasing number of the population that are afflicted and the general lack of effective treatments. The emphasis of this symposium will be on the genetic, cellular and molecular basis of neurodegenerative diseases including Alzheimer’s, Parkinson’s, Huntington’s, Amyotrophic Lateral Sclerosis and Prion disease. The meeting will cover the major mechanisms linked to neurodegeneration and highlight the similarities and differences between the diseases. A strong emphasis will be placed on the development of targeted drug therapies and potential treatment options.


    This meeting aims to bring together basic and clinical research scientists working on different forms of neurodegeneration with their counterparts from the biotechnology and pharma industry to apply recent insights gained in the mechanisms of neurodegenerative diseases and the development of drug therapies. This symposium will bridge the gap between basic research and medical research in an area that urgentlyrequires therapeutic progress, and emphasise the public health challenges in a public forum with senior public heath officials, research scientists, industry representatives and patient advocates.

    Symposium Topics

    • Mechanisms of neuronal and cognitive dysfucntion
    • RNA, RNA binding proteins and RNA translation
    • Chaperones, autophagy and mitochondria
    • Disease progression
    • Novel therapeutic approaches
    • Translating to the clinic


    Keynote Speaker

    • Thomas Südhof – Stanford University School of Medicine, United States of America

    Confirmed Speakers

    • Adriano Aguzzi – University Hospital of Zurich, Switzerland
    • John Collinge – University College London, United Kingdom
    • Ana Maria Cuervo – Albert Einstein College of Medicine, Yeshiva University, United States of America
    • Beverly Davidson – University of Iowa, United States of America
    • Hans-​Ulrich Demuth – Fraunhofer-​Institute of Cell Therapy and Immunology (IZI) Leipzig, Dept. Drug Design & Target Validation, Halle (Saale), Germany
    • Chad Dickey – University of South Florida, United States of America
    • Dieter Edbauer – German Center for Neurodegenerative Diseases (DZNE), Germany
    • André Fischer – Göttingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences, Germany
    • Jürgen Götz – Queensland Brain Institute, The University of Queensland, Australia
    • Michael Heneka – University Hospital Bonn, Germany
    • David Holtzman – Washington University School of Medicine, United States of America
    • Bradley Hyman – Massachusetts General Hospital, United States of America
    • Mathias Jucker – Hertie Institute for Clinical Brain Research and DZNE, Germany
    • Virginia Lee – University of Pennsylvania School of Medicine, United States of America

    Scientific Organisers

    • Karin Dumstrei – The EMBO Journal, Germany
    • Todd Golde – Center for Translational Research in Neurodegenerative Disease, University of Florida, United States of America
    • Christian Haass – German Center for Neurodegenerative Diseases (DZNE), Germany
    starting: ending: 17.06.2015 Location: , Category:


    Conference START 17.06.2015 END

    All deadlines have expired!

    This conference has no more open deadlines. There may be successive conferences coming up you may by interested in.

    Please check our conference list and search...

    Conference Facts

    Location , Address Meyerhofstrasse 1 Category Organiser More Info Conference Website

    Further interesting Conferences

    Currently we have no similar events listed. Please check our website regulary, subscribe to our RSS-Feed or follow us on twitter for new listings.